Today, the S&P/ASX 200 Index (ASX: XJO) edged higher to finish the week slightly below where it started at the beginning of the week. At the closing bell, the benchmark index finished 0.22% higher at 7,241.2 points.

The majority of shares in the Aussie index finished higher today. However, an underwhelming performance from some of the market’s bigger companies prevented a better day more broadly. Leading the market higher were energy shares following a rise in oil prices overnight. At the other end of the ASX were healthcare shares, including a 2.5% fall in CSL Limited (ASX: CSL).

However, the question is: which shares delivered the biggest returns to investors on the ASX today? Here are the top ten stocks that came through for investors:

Top 10 ASX shares countdown today

Looking at the top 200 listed companies, Pro Medicus Ltd (ASX: PME) was the biggest gainer today. Shares in the imaging software company rose 3.79% despite there being no announcements. Accounting for today’s gain, Pro Medicus shares are still down 2% this past month. Find out more about Pro Medicus here.

The next biggest gaining ASX share today was Washinton H Soul Pattinson & Company Ltd (ASX: SOL). The diversified investment house witnessed a 3.34% uptick in its share price today. This might have been due in part to its exposure to energy investments. Uncover the latest Soul Patts details here.

Today’s top 10 biggest gains were made in these ASX shares:

ASX-listed company	Share price	Price change
Pro Medicus Ltd (ASX: PME)	$57.78	3.79%
Washington Soul Pattinson & Company Ltd (ASX: SOL)	$32.16	3.34%
Corporate Travel Management Ltd (ASX: CTD)	$22.36	3.09%
Zimplats Holdings Ltd (ASX: ZIM)	$22.20	3.02%
Whitehaven Coal Ltd (ASX: WHC)	$2.44	2.95%
ALS Ltd (ASX: ALQ)	$12.65	2.85%
Premier Investments Ltd (ASX: PMV)	$30.81	2.77%
QBE Insurance Group Ltd (ASX: QBE)	$12.01	2.74%
Oil Search Ltd (ASX: OSH)	$3.94	2.60%
Bluescope Steel Ltd (ASX: BSL)	$20.47	2.45%

Our top 10 ASX shares today countdown is a recurring end-of-day summary to ensure you know which companies were making big moves on the day. Check-in at Fool.com.au after the market has closed during weekdays to see which stocks make the countdown.

The post Here are the top 10 ASX shares today appeared first on The Motley Fool Australia.

More reading

• These 3 ASX 200 shares are topping the volume charts this Friday
• ASX 200 (ASX:XJO) midday update: BHP higher on unification plans, TPG tumbles
• 5 things to watch on the ASX 200 on Friday
• Here are the top 10 ASX shares today
• Why is the Vanguard Australian Shares Index ETF (ASX:VAS) the most successful Aussie ETF?

Motley Fool contributor Mitchell Lawler owns shares of Pro Medicus Ltd. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. and Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Pro Medicus Ltd. and Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia has recommended Corporate Travel Management Limited and Premier Investments Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3rt1reN

The Envirosuite Ltd (ASX: EVS) share price finished in the red today after returning from its trading halt on Friday morning.

At the close of trading for the week, Envirosuite shares were down 2.22%, swapping hands at 22 cents a piece.

Trading was paused while the environmental management solutions company conducted a capital raise to drive growth in its water treatment technology segment.

What’s happening with Envirosuite?

The catalyst for the Envirosuite share price drop today may have been the capital raise, which dilutes the value of each share. A total of 52.3 million new shares were placed on the market at 20 cents a piece.

The shares were offered at a 15% discount on a share price high of 23.5 cents on 25 November.

As a result, Envirosuite achieved its goal of raising $10.5 million and hailed the capital raise a success.

Furthermore, the company will use proceeds of the capital raise to invest in growing the direct sales in its EVS Water product. This includes growing the sales team and forming new partnerships to achieve sales success.

EVS Water is a 3-product platform that links artificial intelligence with leading water modelling approaches. It helps companies reduce their operational risk and expenses while remaining compliant.

Management commentary

Envirosuite chief executive officer Jason Cooper said:

This capital raising is about growth. That we have been able to raise capital in a highly sought-after placement at a materially superior price than the previous tranche of growth funding is indicative of the trajectory of the business and investors’ appreciation of the opportunity that lies before us.

Envirosuite share price snapshot

Envirosuite shares have grown around 17% in the past 12 months. To put this in perspective, the S&P/ASX 200 Index (ASX: XJO) has climbed around 9% in that time. The Envirosuite share price is down 6.4% over the past month.

The post Here’s why the Envirosuite (ASX:EVS) share price fell today appeared first on The Motley Fool Australia.

More reading

• Halt! Why is the Envirosuite (ASX:EVS) share price paused?
• Envirosuite (ASX:EVS) share price jumps 5% on strategic splash with GHD
• This deal just caused the Envirosuite (ASX:EVS) share price to pop

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3Iiy9pe

Another annual Sohn Hearts & Minds Investment Conference has come to pass today. Charlie Munger warned of bubbly valuations reminiscent of the dot-com era, a few ASX-listed shares received a shoutout, and attendees walked away with a lot of ideas to ponder.

While ASX investors only had a few Australian stock picks, the raft of ideas for international opportunities was extensive. Investing experts laid down investment opportunities situated in Hong Kong to London and everywhere in between.

What shares are the experts betting on?

Investors will be busy tonight trawling through annual reports and doing research after being bombarded with investment opportunities today. Although, out of the 13 speakers, only three mentioned ASX-listed shares as their highest conviction pick — and out of those three, one was a tip to short shares.

Shares in Flight Centre Travel Group Ltd (ASX: FLT) finished flat today despite Regal Funds chief investing officer Philip King placing a target on the company’s back. At the conference, King made his belief known that the company’s shares are overpriced considering the trouble it might have ahead of it still. Namely, the pressure it could face by more competitive online travel offerings.

On the other hand, both Megaport Ltd (ASX: MP1) and Pinnacle Investment Management Group Ltd (ASX: PNI) copped rave reviews by Eleanor Swanson and David Allingham respectively. Notably, Swanson named Megaport as “the most exciting tech adventure of this decade”. The shares in both ASX-listed companies finished the day higher.

Beyond these top picks for 2022, the industry experts delivered a long list of companies that local investors might not have heard of before. However, as we found out, these obscure investment opportunities might be more familiar than originally thought.

For instance, Qiao Ma’s pick of Techtronic Industries Co. Ltd. (HKG: 0669) is the seller of numerous power tool brands including Milwaukee and Ryobi.

All 13 investment opportunities for 2022 revealed

Every stock pick from the Sohn Hearts & Minds Investment Conference is listed below:

Share pick	Share price	Market Capitalisation	Speaker
Bengo4.com Inc (TYO: 6027)	$6,030	A$1.68 billion	Jay Kahn
Techtronic Industries Co Ltd (HKG: 0669)	$172.80	A$57.51 billion	Qiao Ma
Avalara Inc (NYSE: AVLR)	$132.99	A$16.34 billion	Babak Poushanchi
Megaport Ltd (ASX: MP1)	$20.99	A$3.31 billion	Eleanor Swanson
Spotify Technology (NYSE: SPOT)	$228.54	A$61.87 billion	Hamish Corlett
Delivery Hero (ETR: DHER)	$107.40	A$43.92 billion	Beeneet Kothari
GitLab Inc (NASDAQ: GTLB)	$91.23	A$18.39 billion	Yen Liow
Flight Centre Travel Group Ltd (ASX: FLT)	$17.24	A$3.44 billion	Phil King
ON Semiconductor Corp (NASDAQ: ON)	$62.54	A$38.07 billion	Nick Griffin
Wise PLC (LON: WISE)	$738.25	A$13.78 billion	Markus Bihler
Beauty Health Co (NASDAQ: SKIN)	$23.81	A$5.03 billion	Joyce Meng
Coinbase Global Inc (NASDAQ: COIN)	$284.71	A$86.58 billion	Gavin Baker
Pinnacle Investment Management Group Ltd (ASX: PNI)	$15.82	A$3.15 billion	David Allingham

Despite the enthusiasm from these stock pickers, a cloud of scepticism was cast by Berkshire Hathaway‘s Charlie Munger. The renowned longtime investor put some doubt on current market valuations with his commentary, saying:

Some of the valuations we saw in the dot-com era were higher. But overall I consider this even crazier than the dot.com era.

In addition, Munger handed down his grilling critique of cryptocurrency. Warren Buffett’s right-hand man said, “I wish they’d never been invented.”

All in all, it was an incredibly eventful day. But now, investors have a bigger bank of potential share ideas for the year ahead.

The post Winning shares for 2022: the companies experts are backing revealed at Sohn appeared first on The Motley Fool Australia.

More reading

• This fundie is picking GitLab shares as the next potential 10x opportunity
• Flight Centre (ASX:FLT) share price falls again amid Sohn short pick
• Why this fundie thinks Megaport (ASX:MP1) shares are ‘the most exciting tech adventure of this decade’
• Is the Qantas (ASX:QAN) share price at risk of a capital raise?
• 3 ASX travel shares to buy while Omicron scares everyone

Motley Fool contributor Mitchell Lawler owns shares of Spotify Technology. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended MEGAPORT FPO and PINNACLE FPO. The Motley Fool Australia owns shares of and has recommended PINNACLE FPO. The Motley Fool Australia has recommended Berkshire Hathaway (B shares), Flight Centre Travel Group Limited, and MEGAPORT FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3lRcECr

The CSL Limited (ASX: CSL) share price held the fort during November and finished just over 2% in the green for the month.

While it finished relatively flat, the biotech giant’s share price nudged past its previous 52-week highs. It closed as high as $318 and traded as low as $300 per share.

CSL outperforms broad sector in November

The CSL share price outpaced the S&P/ASX 200 Health Care Index (ASX: XHJ) which traded in an almost synchronised fashion to the Aussie biotech’s share price over the last month.

Near month’s end, the company advised its Seqirus business was granted approval from the US Food and Drug Administration to formulate a multi-dose vial (MDV) version of its Audenz label.  

The particular MDV is described as a cell-based influenza vaccine designed to help protect individuals in the event of an influenza pandemic.

Seqirus has a partnership with the Biomedical Advanced Research and Development Authority (BARDA) where it will be positioned to deliver up to 150 million influenza vaccine doses to the US to combat an influenza pandemic within six months. The CSL share price gained on the back of the news.

CSL vs S&P/ASX 200 Health Care Index: November returns in percentages

Source: Google Finance. Google and the Google logo are registered trademarks of Google LLC, used with permission

CSL also recently advised it had secured financing to develop an incubator and wet space lab to support clinical-stage biotechnology startups. The Victorian government is also set to chip in.

In the company’s words, incubators break down cost barriers and other barriers to entry for start-ups. Incubators offer a ‘one-stop shop’ by minimising cost-prohibitive expenditures that otherwise price small biotechs out of the market.

However, the CSL share price struggled on the day the news was announced.

Several investment firms weighed in with their opinion on CSL’s outlook during the month as well. Morgan Stanley notes competitor Haemonetics Corporation (NYSE: HAE)’s recent earnings update where it lowered its plasma collection guidance moving forwards.

The firm reckons this could be a challenge to CSL’s earnings, particularly with the ever-looming threat of another COVID-19 outbreak that would further diminish plasma donation volumes. Macquarie Group Ltd (ASX: MQG) is more constructive on CSL and values the company at $338 per share.

While it’s been a difficult year to date for CSL, it held onto gains earned from the month earlier, where it bounced off a low of $286.19 in line with the broad sector.

The CSL share price is up around 1% in the past 12 months and around 5% this year to date. In the past month, the company’s share price has slipped just over 3% and it closed the week down 6%.

The post CSL (ASX:CSL) share price holds the line in November appeared first on The Motley Fool Australia.

More reading

• What’s going on with the CSL (ASX:CSL) share price on Friday?
• ASX 200 (ASX:XJO) midday update: BHP higher on unification plans, TPG tumbles
• You want an ASX share to hold for 4 years? Here are 2!
• 5 things to watch on the ASX 200 on Friday
• CSL (ASX:CSL) share price dips amid $10b acquisition rumours

The author has no positions in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. The Motley Fool Australia has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/2ZNz2oc